Cost-Utility Analysis of Injectable Paliperidone Palmitate 3-Month Formulation Versus Injectable Risperidone and Oral Antipsychotics For The Treatment Of Schizophrenia In Colombia
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1263
https://www.valueinhealthjournal.com/article/S1098-3015(18)31566-3/fulltext
Title :
Cost-Utility Analysis of Injectable Paliperidone Palmitate 3-Month Formulation Versus Injectable Risperidone and Oral Antipsychotics For The Treatment Of Schizophrenia In Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31566-3&doi=10.1016/j.jval.2018.04.1263
First page :
Section Title :
Open access? :
No
Section Order :
521